Researchers identify promising protein candidate for metabolic disease treatment

byUniversity of SaskatchewanHepG2/C3A cells express NUCB1/NLP and NUCB2/NESF-1. Credit:Communications Biology(2024). DOI: 10.1038/s42003-024-06314-2University of Saskatchewan (USask)

Updated on: May 30,2024 0

Researchers identify promising protein candidate for metabolic disease treatment

byUniversity of SaskatchewanHepG2/C3A cells express NUCB1/NLP and NUCB2/NESF-1. Credit:Communications Biology(2024). DOI: 10.1038/s42003-024-06314-2University of Saskatchewan (USask)

Updated on:May 30,2024 0

Research suggests fine-tuning of specific excitatory synapse traits could lead to new brain disease treatments

by DGIST (Daegu Gyeongbuk Institute of Science and Technology)Profiling of LAR-RPTP microexon expression repertoires by targeted deep RNA sequencing Credit:Nature Communications(2024). DOI

Updated on: March 30,2024 0

Research suggests fine-tuning of specific excitatory synapse traits could lead to new brain disease treatments

by DGIST (Daegu Gyeongbuk Institute of Science and Technology)Profiling of LAR-RPTP microexon expression repertoires by targeted deep RNA sequencing Credit:Nature Communications(2024). DOI

Updated on:March 30,2024 0

New data shows prevalence of Premenstrual Dysphoric Disorder (PMDD)

New data shows prevalence of Premenstrual Dysphoric Disorder (PMDD)HEALTHMEDICAL SCIENCESMENTAL HEALTHRESEARCH29 January 2024Around 1.6% of women and girls have symptomatic Premenstrual Dysphoric Diso

Updated on: March 11,2024 15

New data shows prevalence of Premenstrual Dysphoric Disorder (PMDD)

New data shows prevalence of Premenstrual Dysphoric Disorder (PMDD)HEALTHMEDICAL SCIENCESMENTAL HEALTHRESEARCH29 January 2024Around 1.6% of women and girls have symptomatic Premenstrual Dysphoric Diso

Updated on:March 11,2024 15

Why MDMA did NOT get FDA approval

Updated on: September 01,2024 0

Why MDMA did NOT get FDA approval

Updated on:September 01,2024 0

Study eases concern at antipsychotics use in pregnancy

byUniversity of New South WalesCrude and propensity score-weighted cumulative incidence (with 95% confidence intervals) for composite neurodevelopmental outcome from age 3–19 years in children o

Updated on: March 28,2024 0

Study eases concern at antipsychotics use in pregnancy

byUniversity of New South WalesCrude and propensity score-weighted cumulative incidence (with 95% confidence intervals) for composite neurodevelopmental outcome from age 3–19 years in children o

Updated on:March 28,2024 0

Familial Alzheimer's disease transferred via bone marrow transplant in mice

byCell PressA painting representing Alzheimer's transmissibility as reported in thisStem Cell Reportsstudy. Credit: Chaahat SinghFamilial Alzheimer's disease can be transferr

Updated on: March 30,2024 0

Familial Alzheimer's disease transferred via bone marrow transplant in mice

byCell PressA painting representing Alzheimer's transmissibility as reported in thisStem Cell Reportsstudy. Credit: Chaahat SinghFamilial Alzheimer's disease can be transferr

Updated on:March 30,2024 0

Mifepristone access is coming before the US Supreme Court. How safe is this abortion pill?

by LAURA UNGAR and MATTHEW PERRONEBoxes of the drug mifepristone sit on a shelf at the West Alabama Women's Center in Tuscaloosa, Ala., on March 16, 2022. On Tuesday, March 26, 2024, the U.S. Supr

Updated on: March 28,2024 0

Mifepristone access is coming before the US Supreme Court. How safe is this abortion pill?

by LAURA UNGAR and MATTHEW PERRONEBoxes of the drug mifepristone sit on a shelf at the West Alabama Women's Center in Tuscaloosa, Ala., on March 16, 2022. On Tuesday, March 26, 2024, the U.S. Supr

Updated on:March 28,2024 0

Study shows that the way the brain learns is different from the way that artificial intelligence systems learn

ARTIFICIAL INTELLIGENCEMEDICAL SCIENCESNEUROSCIENCERESEARCHSCIENCEResearchers from theMRC Brain Network Dynamics Unit and Oxford University’sDepartment of Computer Sciencehave set ou

Updated on: March 11,2024 16

Study shows that the way the brain learns is different from the way that artificial intelligence systems learn

ARTIFICIAL INTELLIGENCEMEDICAL SCIENCESNEUROSCIENCERESEARCHSCIENCEResearchers from theMRC Brain Network Dynamics Unit and Oxford University’sDepartment of Computer Sciencehave set ou

Updated on:March 11,2024 16

Drug development advances in beneficial loss-of-function mutation targets validated by human genetics

by Sichuan International Medical Exchange and Promotion AssociationTargets primarily include PCSK9, ANGPTL3, HSD17B13, KHK, ASGR1, GPR75, CIDEB, and INHBE. Drug types primarily include small molecules

Updated on: March 28,2024 0

Drug development advances in beneficial loss-of-function mutation targets validated by human genetics

by Sichuan International Medical Exchange and Promotion AssociationTargets primarily include PCSK9, ANGPTL3, HSD17B13, KHK, ASGR1, GPR75, CIDEB, and INHBE. Drug types primarily include small molecules

Updated on:March 28,2024 0

Researchers are using RNA in a new approach to fight HIV

FEBRUARY 20, 2024byUniversity of WaterlooGraphical abstract. Credit:Journal of Controlled Release(2024). DOI: 10.1016/j.jconrel.2023.12.043Society learned about the value of mRNA dur

Updated on: March 30,2024 8

Researchers are using RNA in a new approach to fight HIV

FEBRUARY 20, 2024byUniversity of WaterlooGraphical abstract. Credit:Journal of Controlled Release(2024). DOI: 10.1016/j.jconrel.2023.12.043Society learned about the value of mRNA dur

Updated on:March 30,2024 8

Removal of incorrect penicillin allergy labels by non-specialist health care professionals feasible, study shows

byUniversity of BirminghamCredit: CC0 Public DomainPatients who may have been mis-labeled as allergic to penicillin could be safely offered a dose of the oral antibiotic to demonstrate that they

Updated on: March 28,2024 0

Removal of incorrect penicillin allergy labels by non-specialist health care professionals feasible, study shows

byUniversity of BirminghamCredit: CC0 Public DomainPatients who may have been mis-labeled as allergic to penicillin could be safely offered a dose of the oral antibiotic to demonstrate that they

Updated on:March 28,2024 0

First clinical trial of vosoritide for children with hypochondroplasia shows increased growth

byChildren's National HospitalStanding height SDS. Credit:eClinicalMedicine(2024). DOI: 10.1016/j.eclinm.2024.102591Vosoritide's first global Phase II study showed an average

Updated on: April 28,2024 0

First clinical trial of vosoritide for children with hypochondroplasia shows increased growth

byChildren's National HospitalStanding height SDS. Credit:eClinicalMedicine(2024). DOI: 10.1016/j.eclinm.2024.102591Vosoritide's first global Phase II study showed an average

Updated on:April 28,2024 0